Furthermore, bisphosphonates show promosing anti-tumoral effect by supressing osteosarcoma-mediated osteolysis, which is mainly caused by decreased secretion of MCP-1 in osteosarcoma cells [52]. Here, CCL2 is linked to osteosarcoma.